-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on PTC Therapeutics (PTCT)
-
-
-
-
-
-
-
SanDisk stock surges after S&P 500 inclusion announcement
-
-
-
-
-
-
-
Goldman Sachs Reiterates Sell Rating on PTC Therapeutics (PTCT)
-
-
-
-
-
-
-
William Blair Reiterates Outperform Rating on PTC Therapeutics (PTCT)
-
-
-
-
-
-
-
Eli Lilly, Roku among others added to Wells Fargo's tactical ideas list
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) Tops Q3 EPS by 12c, provides guidance
-
-
-
-
-
-
-
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
1,199,633 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

